JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhagat, B.
Right arrow Articles by Shideman, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhagat, B.
Right arrow Articles by Shideman, F. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 140, Issue 3, 317-323, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM OF THE INHIBITORY ACTION OF GUANETHIDINE ON CARDIOVASCULAR RESPONSES TO TYRAMINE AND AMPHETAMINE

B. Bhagat 1 and F. E. Shideman 1

1 Department of Pharmacoloqy and Toxicology, University of Wisconsin, Madison, Wisconsin

The influence of guanethidine on responses of the blood pressure and isolated, atropinized atria of rats to tyramine and amphetamine was studied. Administration of guanethidine to animals anesthetized with urethane produced hypotension, inhibited the pressor actions of tyramine and amphetamine, and potentiated the response to norepinephrine. At this time, catecholamine concentrations in the heart were not significantly altered. Isolated atria also failed to exhibit the usual cardiostimulant responses to tyramine and amphetamine after exposure to guanethidine in the absence of any reduction in their concentrations of catecholamines. Atria from rats whose cardiac catecholamines were depleted by guanethidine did not respond to tyramine or amphetamine. The effects of these amines were restored by incubation of the atria with norepinephrine. Depletion of cardiac catecholamines by guanethidine was prevented by TM-10 (2,6-xylyl choline ether bromide) but not by cocaine. It is suggested that guanethidine may affect the action of sympathomimetic amines in two ways: 1) by inhibiting the release of normal stores of catecholamines by the sympathomimetic amines, an acute effect, and 2) by depleting the tissues of their stores of catecholamines, a delayed effect.

Submitted on January 7, 1963
Accepted on March 25, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.